Kindred Biosciences, Inc. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kindred Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kindred Biosciences, Inc. for January 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2021 | KIN | Kindred Bioscience ... | Wee Wendy | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
Jan 26 2021 | KIN | Kindred Bioscience ... | Wee Wendy | Chief Financial Off ... | Payment of Exercise | F | 4.93 | 3,385 | 16,688 | 49,039 | 52.4 K to 49 K (-6.46 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Wee Wendy | Chief Financial Off ... | Payment of Exercise | F | 4.93 | 4,062 | 20,026 | 52,424 | 56.5 K to 52.4 K (-7.19 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Wee Wendy | Chief Financial Off ... | Buy | M | 0.00 | 7,500 | 0 | 56,486 | 49 K to 56.5 K (+15.31 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Zhan Hangjun | Chief Scientific Of ... | Option Exercise | M | 0.00 | 6,250 | 0 | 6,250 | |
Jan 26 2021 | KIN | Kindred Bioscience ... | Zhan Hangjun | Chief Scientific Of ... | Payment of Exercise | F | 4.93 | 3,385 | 16,688 | 39,306 | 42.7 K to 39.3 K (-7.93 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Zhan Hangjun | Chief Scientific Of ... | Payment of Exercise | F | 4.93 | 3,385 | 16,688 | 42,691 | 46.1 K to 42.7 K (-7.35 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Zhan Hangjun | Chief Scientific Of ... | Buy | M | 0.00 | 6,250 | 0 | 46,076 | 39.8 K to 46.1 K (+15.69 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 37,500 | 0 | 37,500 | |
Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 4.93 | 13,163 | 64,894 | 1,968,353 | 2 M to 2 M (-0.66 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 4.93 | 19,744 | 97,338 | 1,981,516 | 2 M to 2 M (-0.99 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 37,500 | 0 | 2,001,260 | 2 M to 2 M (+1.91 %) |
Jan 22 2021 | KIN | Kindred Bioscience ... | Veszpremi Ervin | Director | Option Exercise | A | 4.44 | 50,000 | 222,000 | 50,000 | |
Jan 22 2021 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 4.44 | 49,000 | 217,560 | 49,000 | |
Jan 22 2021 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 4.44 | 48,500 | 215,340 | 48,500 | |
Jan 22 2021 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Option Exercise | A | 4.44 | 50,000 | 222,000 | 50,000 | |
Jan 22 2021 | KIN | Kindred Bioscience ... | MONTGOMERY HERBERT D | Director | Option Exercise | A | 4.44 | 51,500 | 228,660 | 51,500 | |
Jan 22 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Option Exercise | A | 4.44 | 46,000 | 204,240 | 46,000 | |
Jan 22 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Option Exercise | A | 4.44 | 46,000 | 204,240 | 46,000 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | A | 4.44 | 394,000 | 1,749,360 | 394,000 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 37,500 | 0 | 112,500 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 4.95 | 21,128 | 104,584 | 1,963,760 | 2 M to 2 M (-1.06 %) |
Jan 20 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 37,500 | 0 | 1,984,888 | 1.9 M to 2 M (+1.93 %) |
Jan 20 2021 | KIN | Kindred Bioscience ... | Wee Wendy | Chief Financial Off ... | Option Exercise | A | 4.44 | 83,500 | 370,740 | 83,500 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Wee Wendy | Chief Financial Off ... | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Wee Wendy | Chief Financial Off ... | Payment of Exercise | F | 4.95 | 3,385 | 16,756 | 48,968 | 52.4 K to 49 K (-6.47 %) |
Jan 20 2021 | KIN | Kindred Bioscience ... | Wee Wendy | Chief Financial Off ... | Buy | M | 0.00 | 6,250 | 0 | 52,371 | 46.1 K to 52.4 K (+13.55 %) |
Jan 20 2021 | KIN | Kindred Bioscience ... | Zhan Hangjun | Chief Scientific Of ... | Option Exercise | A | 4.44 | 83,500 | 370,740 | 83,500 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Zhan Hangjun | Chief Scientific Of ... | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Zhan Hangjun | Chief Scientific Of ... | Payment of Exercise | F | 4.95 | 3,385 | 16,756 | 39,826 | 43.2 K to 39.8 K (-7.83 %) |
Jan 20 2021 | KIN | Kindred Bioscience ... | Zhan Hangjun | Chief Scientific Of ... | Buy | M | 0.00 | 6,250 | 0 | 43,211 | 37 K to 43.2 K (+16.91 %) |
Jan 15 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Option Exercise | M | 0.32 | 13,023 | 4,167 | 13,023 | |
Jan 15 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Sell | S | 5.00 | 13,023 | 65,115 | 0 | 13 K to 0 (-100.00 %) |
Jan 15 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Buy | M | 0.32 | 13,023 | 4,167 | 13,023 | 0 to 13 K |
Jan 08 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Option Exercise | M | 0.32 | 23,567 | 7,541 | 26,046 | |
Jan 08 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Option Exercise | M | 0.32 | 15,502 | 4,961 | 0 | |
Jan 08 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Sell | S | 5.00 | 39,069 | 195,349 | 0 | 39.1 K to 0 (-100.00 %) |
Jan 08 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Buy | M | 0.32 | 23,567 | 7,541 | 39,069 | 15.5 K to 39.1 K (+152.03 %) |
Jan 08 2021 | KIN | Kindred Bioscience ... | Bevers Denise | Director | Buy | M | 0.32 | 15,502 | 4,961 | 15,502 | 0 to 15.5 K |